2017
DOI: 10.1186/s13036-016-0046-z
|View full text |Cite
|
Sign up to set email alerts
|

Future developments in biosensors for field-ready Zika virus diagnostics

Abstract: Since early reports of the recent Zika virus outbreak in May 2015, much has been learned and discussed regarding Zika virus infection and transmission. However, many opportunities still remain for translating these findings into field-ready sensors and diagnostics. In this brief review, we discuss current diagnostic methods, consider the prospects of translating other flavivirus biosensors directly to Zika virus sensing, and look toward the future developments needed for high-sensitivity and high-specificity b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
52
0
7

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 46 publications
(60 citation statements)
references
References 60 publications
1
52
0
7
Order By: Relevance
“…Emerging infectious diseases pose serious public health concern, particularly in rural and resource‐limited settings where prevention is hindered by the extensive time, materials, instrumentation, or infrastructure required by conventional diagnostics . Reflecting on the 2015–2016 Zika virus (ZIKV) outbreak, researchers must explore inexpensive, rapid, portable, and versatile pathogen diagnostics to focus limited resources in field and clinical settings …”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Emerging infectious diseases pose serious public health concern, particularly in rural and resource‐limited settings where prevention is hindered by the extensive time, materials, instrumentation, or infrastructure required by conventional diagnostics . Reflecting on the 2015–2016 Zika virus (ZIKV) outbreak, researchers must explore inexpensive, rapid, portable, and versatile pathogen diagnostics to focus limited resources in field and clinical settings …”
Section: Figurementioning
confidence: 99%
“…This included quantification of net interfacial tension, contact angle, viscosity, and fiber swelling/pore deformation changes (Figure ). These data were used to develop a L –W/C–B capillary flow model, which was validated by a capillary flow dynamics‐based assay for E. coli K12, a well‐characterized bacterial target used in prior scattering‐based immunoagglutination assays, and ZIKV, a virus of recent concern …”
Section: Figurementioning
confidence: 99%
“…Compounds chloromonilicin (3), a-costic acid (4), fusaric acid (8), inuloxin A (13) and 3-nitroprpionic acid (16) showed >90% mortality at the 1.0 µg/µL; however, the activity declined quickly as the compound was diluted. In adult bioassays, compounds (20), pyripyropene A (18), pyripyropene E (19), haemanthidine (11), sphaeropsidin C (21), haemanthamine (10) and cytochalasin A (6) exhibited moderate activity and weak activity was displayed by buphanamine (1), chloromonilicin (3), cytochalasin B (7), inuloxin C (14) and 6-hydroxymellein (12).…”
Section: Resultsmentioning
confidence: 99%
“…In adult bioassays, compounds were tested at the pre-screening dose of 5 µg/mosquito and only four compounds, α-costic acid (4), fusaric acid (8), gliotoxin (9) and 3-nitropropionic acid (16), demonstrated mortality between 83-97% ( Table 2). Based on this initial screening activity data, LD 50 bioassays were conducted and compound 8 was the most effective compounds with an LD 50 value of 0.8349 ± 0.0118 µg/mosquito and followed by compounds 16 (LD 50 value= 1.6641 ± 0.0494 µg/mosquito), 4 (LD 50 value= 2.547 ± 0.0835 µg/mosquito), 9 (LD 50 value= 2.79 ± 0.1197 µg/mosquito) ( Table 2).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation